ESCMID Pipeline Corner
ESCMID offers small innovative pharmaceutical companies with early-stage antimicrobial therapies in development a platform at ECCMID to present their products to a wider audience.
Antimicrobial drug pipeline talks at ECCMID 2017 in Vienna!
ECCMID provided small innovative companies with a platform to give an overview of their R&D pipelines and present recent advances in their early-stage programmes to a wider audience.
Sunday, 23 April 2017
12:30 – 14:00, Foyer E
12:30 – 13:20 Pipeline talks
13:20 – 13:30 Experience report
13:30 – 14:00 Discussion, networking
ePosters are accessible via the congress app and on dedicated terminals until the end of the congress on 25 April.
Presenting companies
• AiCuris GmbH, Germany (ePoster only)
• Allecra Therapeutics GmbH, Germany
• Arsanis Biosciences, Austria/United States
• Cantab Anti-infectives Ltd, United Kingdom
• Centauri Therapeutics Ltd, United Kingdom (ePoster only)
• Naicons Srl., Italy
• NovaBiotics Ltd, United Kingdom
• Phico Therapeutics Ltd, United Kingdom
• Scynexis Inc., United States (ePoster only)
• Septeos, France (ePoster only)
• Synthetic Biologics Inc., United States
• TAXIS Pharmaceuticals Inc., United States
Experience report of Redx Pharma, United Kingdom, with Carb-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a private-public initiative that invests in companies and research teams with antimicrobial products in development.
Pipeline talks at ECCMID 2016 in Amsterdam
After successful initiation of the Pipeline Corner and the Pipeline Talks at ECCMID 2015 in Copenhagen, the ECCMID Programme Committee extend the new format at ECCMID 2016 in Amsterdam.
The dedicated session took place at ECCMID 2016 in Amsterdam on Sunday, 10 April 2016, 13:00 - 14:00
Presenting companies:
- BioVersys, Switzerland
- Melinta, United States
- Deutsches Zentrum für Infektionsforschung, Germany
- Discuva, United Kingdom
- Cidara, United States
- Spero, United States
- ABAC Therapeutics, Spain
- Biovertis, Germany
- Nabriva, Austria
- Vitas Pharma, India
Pipeline Corner at ECCMID 2015
The dedicated Pipeline Corner at ECCMID 2015 generated great interest among the research community, larger pharmaceutical companies, service providers, venture capital firms, and the press. The display of electronic posters has proved to be the starting point for promising discussions and meetings throughout the conference.
The posters can be found in our eLibrary under this link.
This list displays European or international initiatives active in combatting antimicrobial resistance by developing new compounds. If you would like to add a new European or international initiative or amend an existing entry, please contact the ESCMID Office.
Driving reinvestment in R&D for antibiotics and advocating their responsible use
CDC Antibiotic Resistance Solutions Initiative
Joint Programme Initiative on Antimicrobial Resistance
